In this paper the benefits of B. bovis vaccination are valued, and the decrease in expenditure on the diagnosis and treatment of disease determined and valued. The costs associated with the B. bovis vaccination program are then identified, quantified and valued. The effect of changes in disease incidence, level of natural disease resistance in the herd, and choice of discount rate on economic performance criteria are examined in model simulations.